Apogee Therapeutics, Common Stock Market Value
| APGE Stock | 43.38 0.43 0.98% |
| Symbol | Apogee |
Apogee Therapeutics, Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apogee Therapeutics,. If investors know Apogee will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apogee Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Apogee Therapeutics, is measured differently than its book value, which is the value of Apogee that is recorded on the company's balance sheet. Investors also form their own opinion of Apogee Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Apogee Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apogee Therapeutics,'s market value can be influenced by many factors that don't directly affect Apogee Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apogee Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Apogee Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apogee Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Apogee Therapeutics, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Apogee Therapeutics,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Apogee Therapeutics,.
| 03/30/2025 |
| 06/28/2025 |
If you would invest 0.00 in Apogee Therapeutics, on March 30, 2025 and sell it all today you would earn a total of 0.00 from holding Apogee Therapeutics, Common or generate 0.0% return on investment in Apogee Therapeutics, over 90 days. Apogee Therapeutics, is related to or competes with STMicroelectronics, CVS Health, Academy Sports, ASE Industrial, Cosan SA, and Micron Technology. Apogee Therapeutics, is entity of United States More
Apogee Therapeutics, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Apogee Therapeutics,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Apogee Therapeutics, Common upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.99 | |||
| Information Ratio | 0.0362 | |||
| Maximum Drawdown | 20.15 | |||
| Value At Risk | (7.51) | |||
| Potential Upside | 7.29 |
Apogee Therapeutics, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Apogee Therapeutics,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Apogee Therapeutics,'s standard deviation. In reality, there are many statistical measures that can use Apogee Therapeutics, historical prices to predict the future Apogee Therapeutics,'s volatility.| Risk Adjusted Performance | 0.0817 | |||
| Jensen Alpha | 0.1399 | |||
| Total Risk Alpha | 0.1036 | |||
| Sortino Ratio | 0.0384 | |||
| Treynor Ratio | 0.1297 |
Apogee Therapeutics, Backtested Returns
Apogee Therapeutics, appears to be very steady, given 3 months investment horizon. Apogee Therapeutics, secures Sharpe Ratio (or Efficiency) of 0.0776, which signifies that the company had a 0.0776 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Apogee Therapeutics, Common, which you can use to evaluate the volatility of the firm. Please makes use of Apogee Therapeutics,'s Mean Deviation of 3.16, risk adjusted performance of 0.0817, and Downside Deviation of 3.99 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Apogee Therapeutics, holds a performance score of 6. The firm shows a Beta (market volatility) of 1.42, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Apogee Therapeutics, will likely underperform. Please check Apogee Therapeutics,'s downside variance, daily balance of power, and the relationship between the maximum drawdown and skewness , to make a quick decision on whether Apogee Therapeutics,'s price patterns will revert.
Auto-correlation | 0.74 |
Good predictability
Apogee Therapeutics, Common has good predictability. Overlapping area represents the amount of predictability between Apogee Therapeutics, time series from 30th of March 2025 to 14th of May 2025 and 14th of May 2025 to 28th of June 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Apogee Therapeutics, price movement. The serial correlation of 0.74 indicates that around 74.0% of current Apogee Therapeutics, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.74 | |
| Spearman Rank Test | 0.4 | |
| Residual Average | 0.0 | |
| Price Variance | 5.65 |
Apogee Therapeutics, lagged returns against current returns
Autocorrelation, which is Apogee Therapeutics, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Apogee Therapeutics,'s stock expected returns. We can calculate the autocorrelation of Apogee Therapeutics, returns to help us make a trade decision. For example, suppose you find that Apogee Therapeutics, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Apogee Therapeutics, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Apogee Therapeutics, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Apogee Therapeutics, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Apogee Therapeutics, stock over time.
Current vs Lagged Prices |
| Timeline |
Apogee Therapeutics, Lagged Returns
When evaluating Apogee Therapeutics,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Apogee Therapeutics, stock have on its future price. Apogee Therapeutics, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Apogee Therapeutics, autocorrelation shows the relationship between Apogee Therapeutics, stock current value and its past values and can show if there is a momentum factor associated with investing in Apogee Therapeutics, Common.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Apogee Therapeutics, is a strong investment it is important to analyze Apogee Therapeutics,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Apogee Therapeutics,'s future performance. For an informed investment choice regarding Apogee Stock, refer to the following important reports:Check out Apogee Therapeutics, Correlation, Apogee Therapeutics, Volatility and Apogee Therapeutics, Alpha and Beta module to complement your research on Apogee Therapeutics,. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Apogee Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.